Literature DB >> 18055660

Gender differences in presentation and course of disease in pediatric patients with Crohn disease.

Neera Gupta1, Alan G Bostrom, Barbara S Kirschner, George D Ferry, Harland S Winter, Robert N Baldassano, Benjamin D Gold, Oren Abramson, Terry Smith, Stanley A Cohen, Melvin B Heyman.   

Abstract

OBJECTIVE: The objective of this study was to determine gender differences in pediatric patients with Crohn disease.
METHODS: We conducted a retrospective cohort study of 989 consecutive pediatric patients (566 boys, 423 girls) who had Crohn disease (aged 0 to 17 years at diagnosis) by using the Pediatric IBD Consortium Registry. Uniform data were analyzed to compare the presentation and course of disease according to gender.
RESULTS: Median follow-up time was 2.8 years. Mean +/- SD age at diagnosis of inflammatory bowel disease (11.5 +/- 3.8 years) did not differ by gender. Compared with boys, girls had a higher prevalence of mouth sores at symptom onset and a higher prevalence of hypoalbuminemia at the time of diagnosis. Location of disease did not differ by gender. A higher proportion of girls had abnormal anti-outer membrane porin of Escherichia coli levels compared with boys. Girls were at increased risk for erythema nodosum/pyoderma gangrenosum and decreased risk for growth failure compared with boys.
CONCLUSIONS: Girls appear to have an overall more severe course of disease; however, boys are at increased risk for developing growth failure. Disease course and the impact of disease severity on growth according to gender in pediatric Crohn disease require prospective study.

Entities:  

Mesh:

Year:  2007        PMID: 18055660     DOI: 10.1542/peds.2007-0905

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  31 in total

1.  Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Marjorie McCracken; Eric Vittinghoff
Journal:  Inflamm Bowel Dis       Date:  2011-02-01       Impact factor: 5.325

2.  Presentation and disease course in early- compared to later-onset pediatric Crohn's disease.

Authors:  Neera Gupta; Alan G Bostrom; Barbara S Kirschner; Stanley A Cohen; Oren Abramson; George D Ferry; Benjamin D Gold; Harland S Winter; Robert N Baldassano; Terry Smith; Melvin B Heyman
Journal:  Am J Gastroenterol       Date:  2008-08       Impact factor: 10.864

3.  Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation.

Authors:  Burcu Hasdemir; Pallavi Mhaske; Sreenivasan Paruthiyil; Elizabeth A Garnett; Melvin B Heyman; Mehrdad Matloubian; Aditi Bhargava
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

Review 4.  IBD in the Elderly: Management Challenges and Therapeutic Considerations.

Authors:  Vivy Tran; Berkeley N Limketkai; Jenny S Sauk
Journal:  Curr Gastroenterol Rep       Date:  2019-11-27

5.  Transmission distortion in Crohn's disease risk gene ATG16L1 leads to sex difference in disease association.

Authors:  Linda Y Liu; Marc A Schaub; Marina Sirota; Atul J Butte
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

Review 6.  Diagnosis and management of inflammatory bowel disease in children.

Authors:  Stephanie B Oliveira; Iona M Monteiro
Journal:  BMJ       Date:  2017-05-31

7.  Impact of sex on 30-day complications and long-term functional outcomes following ileal pouch-anal anastomosis for chronic ulcerative colitis.

Authors:  Nicholas P McKenna; Eric J Dozois; John H Pemberton; Amy L Lightner
Journal:  Int J Colorectal Dis       Date:  2018-03-16       Impact factor: 2.571

Review 8.  Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease.

Authors:  Hengameh Chloé Mirsepasi-Lauridsen; Bruce Andrew Vallance; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

9.  Infliximab dosing patterns in a sample of patients with Crohn's disease: results from a medical chart review.

Authors:  Joseph Tkacz; Jennifer H Lofland; Julie Vanderpoel; Charles Ruetsch
Journal:  Am Health Drug Benefits       Date:  2014-04

10.  Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients.

Authors:  Neera Gupta; Alan G Bostrom; Barbara S Kirschner; George D Ferry; Benjamin D Gold; Stanley A Cohen; Harland S Winter; Robert N Baldassano; Oren Abramson; Terry Smith; Melvin B Heyman
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.